Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-03-03

Clinical Trial Update: Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis

View source ↗

Summary

A completed clinical trial examining how infliximab drug levels correlate with outcomes in ulcerative colitis, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Infliximab (infliximab)

Snippet

Sponsor: Mayo Clinic | Conditions: Colitis, Ulcerative, Inflammatory Bowel Disease | Status: COMPLETED | Results posted: 2022-03-03